SikaForce -7900 (B)

Hazard statements (CLP)

H315, H317, H319, H332, H334, H335, H351, H373

Code

Statements

H315

Causes skin irritation

SECTION 2: Hazards identification

Regulation (EC) No. 1272/2008 Classification of the substance or mixture

Signal word

Danger

Hazard statements

H315 Causes skin irritation. H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. H332 Harmful if inhaled. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H335 May cause respiratory irritation. H351 Suspected of causing cancer. H373 May cause damage to organs through pro- longed or repeated exposure if inhaled.

Prevention

P201 Obtain special instructions before use. P260 Do not breathe mist or vapours. P264 Wash skin thoroughly after handling. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection.

Response

P304 + P340 + P312 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/ doctor if you feel unwell. P342 + P311 If experiencing respiratory symptoms: Call a POISON CENTER/ doctor.

Hazardous Ingredients

Formaldehyde, oligomeric reaction products with aniline and phosgene 4,4`-Methylenediphenyl diisocyanate, oligomers

Additional information

EUH211 Warning! Hazardous respirable droplets may be formed when sprayed. Do not breathe spray or mist. "As from 24 August 2023 adequate training is required before industrial or pro- fessional use."

2.3 Other hazards

This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.

ECOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have en- docrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.

TOXICOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regula- tion (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.

2.1 Classification of the substance or mixture

Classification (REGULATION (EC) No 1272/2008) Acute toxicity, Category 4 H332: Harmful if inhaled. Skin irritation, Category 2 H315: Causes skin irritation. Eye irritation, Category 2 H319: Causes serious eye irritation. Respiratory sensitisation, Category 1 H334: May cause allergy or asthma symptoms or breathing difficulties if inhaled. Skin sensitisation, Category 1 H317: May cause an allergic skin reaction. Carcinogenicity, Category 2 H351: Suspected of causing cancer. Specific target organ toxicity - single ex- H335: May cause respiratory irritation. posure, Category 3, Respiratory system Specific target organ toxicity - repeated H373: May cause damage to organs through pro- exposure, Category 2 longed or repeated exposure if inhaled.